Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:6:297-322.
doi: 10.2147/PPA.S30244. Epub 2012 Apr 5.

The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review

Affiliations

The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review

Parya Saberi et al. Patient Prefer Adherence. 2012.

Abstract

Objective: Due to the rapid proliferation of human immunodeficiency virus (HIV) treatment options, there is a need for health care providers with knowledge of antiretroviral therapy intricacies. In a HIV multidisciplinary care team, the HIV pharmacist is well-equipped to provide this expertise. We conducted a systematic review to assess the impact of HIV pharmacists on HIV clinical outcomes.

Methods: We searched six electronic databases from January 1, 1980 to June 1, 2011 and included all quantitative studies that examined pharmacist's roles in the clinical care of HIV-positive adults. Primary outcomes were antiretroviral adherence, viral load, and CD(4) (+) cell count and secondary outcomes included health care utilization parameters, antiretroviral modifications, and other descriptive variables.

Results: Thirty-two publications were included. Despite methodological limitation, the involvement of HIV pharmacists was associated with statistically significant adherence improvements and positive impact on viral suppression in the majority of studies.

Conclusion: This systematic review provides evidence of the beneficial impact of HIV pharmacists on HIV treatment outcomes and offers suggestions for future research.

Keywords: HIV/AIDS; adherence; clinical; impact; pharmacist.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Selection process for study inclusion.

Similar articles

Cited by

References

    1. Centers for Disease Control (CDC) Pneumocystis pneumonia – Los Angeles. MMWR Morb Mortal Wkly Rep. 1981;30(21):250–252. - PubMed
    1. Corelli RL, Guglielmo BJ, Kapusnik-Uner JE, McMaster JR, Greenblatt RM. Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review. DICP. 1991;25(12):1374–1378. - PubMed
    1. Crawford NS. Organizing pharmacists to help fight AIDS. Am Pharm. 1991;NS31(3):44–47. - PubMed
    1. McKnight PT, Visconti JA, Gower RE, Para MF. Zidovudine: counseling strategies and Compliance. Am Pharm. 1991;31(10):38–43. - PubMed
    1. Weingarten CM, Freeland B. Pharmacist participation on an HIV resource team. Am J Health Syst Pharm. 1995;52(12):1282–1284. - PubMed